Corvus touts ear­ly da­ta on T cell lym­phoma drug, makes PhI­II plans

Corvus Phar­ma­ceu­ti­cals said that its T cell lym­phoma drug helped shrink tu­mors in pa­tients whose can­cer had re­lapsed, ac­cord­ing to an ear­ly cut of da­ta …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.